ArticleMolecular and clinical oncology2026
Long non-coding RNAs affect the metastasis of hepatocellular carcinoma cells by regulating the epithelial-to-mesenchymal transition.
Article in Molecular and clinical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, and, in terms of its global incidence and mortality rates across all types of cancer, HCC is ranked sixth and third, respectively. Therefore, HCC is a notable global health burden. Dysregulation of long non-coding RNAs (lncRNAs) has a key role in human tumorigenesis. However, the lncRNAs involved in the epithelial-to-mesenchymal transition (EMT) that affects the migration and recurrence of HCC are yet to be fully elucidated. In the present study, the EMT was induced in Huh7 cells using transforming growth factor-β (TGF-β) and it was revealed that this process may promote HCC metastasis. RNA sequencing was then used to screen the lncRNAs and mRNAs that were differentially expressed (DE) during the TGF-β-induced EMT process. Subsequently, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analyses were carried out on the identified DE lncRNAs and mRNAs. By constructing a co-expression network of DE lncRNAs and mRNAs, key lncRNAs possibly involved in the TGF-β-induced EMT that may promote the metastasis of HCC were predicted. Therefore, although preliminary, the present study suggested a list of potential candidates for further investigation of the molecular mechanism of the TGF-β-induced EMT in HCC. Further research may reveal key information on tumorigenesis and potential therapeutic targets in HCC in the future.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.